Postoperative benign prostatic hyperplasia
Conditions
Interventions
Dexamethasone group:The local anesthetic was 0.3% ropivacaine 8.75ml+dexamethasone 1ml (5mg)+0.9% normal saline 0.25ml.
Dexamethasone combined with dexmedetomidine group:The local anesthetic was 0.3% ropivacaine 8.75ml+dexamethasone 1ml (5mg)+dexmedetomidine 0.25ml (25ug).
Sponsors
The Third Affiliated Hosptial of ChongQing Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years; 2. American Society of Anesthesiologists (ASA) class 1-3; 3. Benign prostatic hyperplasia confirmed by B-ultrasound, urodynamics, and serum prostate-specific antigen; 4. Preoperative coagulation was normal, and there was no contraindication of spinal anesthesia and nerve block; 5. Transurethral enucleation of the prostate was selected; 6. No chronic pain. 7. No cognitive impairment.
Exclusion criteria
Exclusion criteria: 1. Prostate cancer; 2. Neurogenic bladder; 3. Bladder neck sclerosis or other urethral diseases; 4. Refuse intraspinal anesthesia and nerve block; 5. Allergic to local anesthetics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective time of pudendal nerve; | — |
Secondary
| Measure | Time frame |
|---|---|
| the incidence of Bladder spasm 3 days after the operation.;Catheter related bladder discomfort score;Duration of sensory block;Block-related complications:;Visual analog scale scores; | — |
Countries
China
Contacts
Public ContactYinan Deng
The Third Affiliated Hosptial of ChongQing Medical University
Outcome results
None listed